Associate Director FAS LAB
Evonik Corporation/ St. Johns University
hillsborough, New Jersey
Mohammed Irfan Syed is an Associate Director at Formulation Application Services Lab of Evonik at Piscataway, NJ, USA. He currently heads the formulation group, focused on developing novel oral drug delivery systems of immediate, delayed and sustained release products using Eudragit and Eudraguard line of Polymers. During his career he has held several positions in CRO’s, CMO’s, Generic and OTC organizations and has developed several complex solid and liquid oral modified release dosage forms. Some of his work on oral transmucosal and self-emulsifying drug delivery systems for specific diseases, which has been patented. He holds bachelor’s in pharmaceutical sciences, master’s in chemistry and is currently pursuing PhD in pharmaceutical sciences. During his academic journey he has presented his work on gastro retentive drug delivery systems, nanoparticles/solid dispersion formulations in several scientific organizations. His current research is on promotion of personalized medication through development of Immediate release 3D Printing tablets by fused deposition modelling technique. He believes lygometry is the way to grow oneself and as a team
Disclosure information not submitted.
Oral Delivery of Microbiome Utilizing Functional Capsules in Clinical Trial-1B
Tuesday, October 22, 2024
3:45 PM – 4:00 PM MT